Personalized cancer vaccine trial halted Mid-Study
NCT ID NCT06175221
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This trial tested a personalized cancer vaccine made from a patient's own tumor cells. It aimed to see if the vaccine could slow tumor growth or improve survival in people with various solid tumors. The study was stopped early, but researchers were looking at safety, immune response, and how long patients lived.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Southside Medical Center
Greenville, South Carolina, 29615, United States
Conditions
Explore the condition pages connected to this study.